(Q51935059)

English

Identification of the time-point which gives a plasma rabeprazole concentration that adequately reflects the area under the concentration-time curve.

scientific article published on 17 August 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16915367

Identification of the time-point which gives a plasma rabeprazole concentration that adequately reflects the area under the concentration-time curve. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16915367

(RS)-rabeprazole

0 references

Norio Yasui-Furukori

3

object named as

Norio Yasui-Furukori

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

author name string

Takenori Niioka

1

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16915367

Tsukasa Uno

2

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16915367

Mikiko Shimizu

4

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16915367

Kazunobu Sugawara

5

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16915367

Tomonori Tateishi

6

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16915367

publication date

17 August 2006

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16915367

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16915367

62

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16915367

10

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16915367

855-861

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16915367

CYP2C19 polymorphism and proton pump inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS00228-006-0184-1

21 January 2018

A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the kinetic disposition of and serum gastrin change by lansoprazole versus rabeprazole during an 8-day dosing scheme in relation to CYP2C19 polymorphism

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of liver disease on pharmacokinetics. An update

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of CYP2C19 genotypic differences in the metabolism of omeprazole and rabeprazole on intragastric pH.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low daily 10-mg and 20-mg doses of fluvoxamine inhibit the metabolism of both caffeine (cytochrome P4501A2) and omeprazole (cytochrome P4502C19).

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized open trial for comparison of proton pump inhibitors, omeprazole versus rabeprazole, in dual therapy for Helicobacter pylori infection in relation to CYP2C19 genetic polymorphism

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-response evaluation of the antisecretory effect of continuous infusion intravenous lansoprazole regimens over 48 h

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of oral rabeprazole on oesophageal and gastric pH in patients with gastro-oesophageal reflux disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review article: cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Different dosage regimens of rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotype status

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacogenetics of the proton pump inhibitors: a systematic review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of frequent dosing of an oral proton pump inhibitor on intragastric pH

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of rabeprazole and its active metabolite, rabeprazole thioether in human plasma by column-switching high-performance liquid chromatography and its application to pharmacokinetic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection and CYP2C19 genetic polymorphism

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rabeprazole: pharmacokinetics in patients with stable, compensated cirrhosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Some suggestions for measuring predictive performance

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rabeprazole in a one-week eradication therapy of Helicobacter pylori: comparison of different dosages

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the kinetic disposition and metabolism of E3810, a new proton pump inhibitor, and omeprazole in relation to S-mephenytoin 4′-hydroxylation status

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of genotypic differences in CYP2C19 status on cure rates for Helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillin

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rabeprazole in treatment of acid peptic diseases: results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD). The Rabeprazole Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The proton pump inhibitor, E3810, binds to the N-terminal half of the alpha-subunit of gastric H+,K(+)-ATPase

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review article: the pharmacokinetics of rabeprazole in health and disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of the area under the plasma concentration vs time curve and the maximum plasma concentration of esomeprazole on intragastric pH.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a single time-point for plasma lansoprazole measurement that adequately reflects area under the concentration-time curve

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of clarithromycin and verapamil on rabeprazole pharmacokinetics between CYP2C19 genotypes

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacogenomics of proton pump inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of CYP2C19 gene polymorphism on cure rates for Helicobacter pylori infection by triple therapy with proton pump inhibitor (omeprazole or rabeprazole), amoxycillin and clarithromycin in Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/16915367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00228-006-0184-1

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16915367

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16915367

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51935059&oldid=2211345040"